The 2012 Italian Infectious Disease Testing Market
US$ 4,720.00
This report presents a comprehensive analysis of the Italian infectious disease testing market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
March 2012
970 pages
The 2012 Japanese Infectious Disease Testing Market
US$ 6,240.00
This report presents a comprehensive analysis of the Japanese infectious disease testing market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
March 2012
976 pages
The 2012 Spanish Infectious Disease Testing Market
US$ 4,720.00
This report presents a comprehensive analysis of the Spanish infectious disease testing market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
March 2012
960 pages
The 2012 UK Infectious Disease Testing Market
US$ 4,720.00
... , demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 ...
March 2012
978 pages
The 2012 US Infectious Disease Testing Market
US$ 7,520.00
... , demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 ...
March 2012
1037 pages
The 2012 French Molecular Diagnostics Market
US$ 4,720.00
... report presents a comprehensive analysis of the French molecular diagnostics market, including: Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...
March 2012
850 pages
The 2012 German Molecular Diagnostics Market
US$ 4,720.00
... report presents a comprehensive analysis of the German molecular diagnostics market, including: Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...
March 2012
850 pages
The 2012 Italian Molecular Diagnostics Market
US$ 4,720.00
... presents a comprehensive analysis of the Italian molecular diagnostics market, including: Major issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...
March 2012
850 pages
The 2012 Japanese Molecular Diagnostics Market
US$ 6,000.00
... presents a comprehensive analysis of the Japanese molecular diagnostics market, including: Major issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...
March 2012
860 pages
The 2012 Spanish Molecular Diagnostics Market
US$ 4,720.00
... presents a comprehensive analysis of the Spanish molecular diagnostics market, including: Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...
March 2012
850 pages
The 2012 UK Molecular Diagnostics Market
US$ 4,720.00
... . Feature comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, ...
March 2012
855 pages
The 2012 US Molecular Diagnostics Market
US$ 6,720.00
... . Feature comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, ...
March 2012
880 pages
The 2012 French Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
542 pages
The 2012 German Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
578 pages
The 2012 Italian Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
561 pages
The 2012 Japanese Clinical Chemistry and Immunodiagnostics Markets
US$ 5,440.00
... and immunodiagnostics markets, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
559 pages
The 2012 Spanish Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... and immunodiagnostics markets, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...
March 2012
568 pages
The 2012 Clinical Chemistry Market: US, Europe, Japan
US$ 10,000.00
... will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This ... devices, controls, calibrators and others. The Clinical Chemistry Market: US, Europe, Japan" is a unique worldwide market and technology assessment designed to help ...
March 2012
520 pages
The 2012 UK Clinical Chemistry and Immunodiagnostics Markets
US$ 4,320.00
... chemistry and immunodiagnostics markets, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, ... market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical ...
March 2012
563 pages
The 2012 US Clinical Chemistry and Immunodiagnostics Markets
US$ 8,560.00
... chemistry and immunodiagnostics markets, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, ... market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical ...
March 2012
600 pages
Opportunities in the Telemedicine Market in India
US$ 1,000.00
Executive
The telemedicine market in India has witnessed significant growth, owing to its potential of providing the world class clinical and medical services to distant and rural locations. The...
March 2012
30 pages
Merck - IMPROVE IT update - Appears trending favorably
US$ 90.00
Today, Merck announced that the Data Safety Monitoring Board has given a go-ahead signal to the IMPROVE-IT after it conducted a pre-specified second interim ... . The company has also indicated that the projected completion of IMPROVE IT by 2013 may change.
March 2012
1 pages
Medicated Skin Care in Argentina
US$ 990.00
... out of every 10 Argentine women in the country wear... Euromonitor International's Medicated Skin Care in Argentina report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
March 2012
30 pages
The World Anesthesia Drug Market (General, Local, Adjunctive)
US$ 3,995.00
This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies ... several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which ...
March 2012
190 pages
Research Report on Chinese Bio-pharmaceutical Industry, 2012
US$ 3,000.00
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In...
March 2012
60 pages
Medicated Skin Care in Estonia
US$ 990.00
Medicated skin care witnessed current value growth of 5% to reach EUR1.6 million in 2011 due to increased consumption. Consumers purchased medicated skin care products more freely in 2011 because ... decreased as well. Due to many positive factors, consumers’... Euromonitor International's Medicated Skin Care in Estonia report offers a comprehensive guide to the size and shape of the ...
March 2012
23 pages
Medicated Skin Care in Russia
US$ 990.00
... consultations with cosmetologists, trichologists and other professionals on... Euromonitor International's Medicated Skin Care in Russia report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
March 2012
43 pages
Fitness & Slimming Industry in India (2011-15)
US$ 500.00
EXECUTIVE SUMMARY
Indian Fitness & Slimming Industry constitutes about 8% of the wellness market. Presently, the fitness industry is in its nascent stages. The industry is fairly fragmented...
March 2012
48 pages
The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living
US$ 3,995.00
... . These twin challenges are addressed in The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living The report ... the Marketplace Competitors and Competitive Analysis Sales estimates for each market segment represent U.S. revenues and are expressed in current dollars. Estimates ...
March 2012
185 pages
Medicated Skin Care in Lithuania
US$ 990.00
... little hesitation about spending on medicines recommended by a dermatologist. Euromonitor International's Medicated Skin Care in Lithuania report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
March 2012
27 pages
Medicated Skin Care in Denmark
US$ 990.00
Medicated skin care grew by 1% in 2011 to reach sales of DKr144 million. The positive growth stemmed from consumers’ increasing willingness to self-medicate and cure their skin ... ) treatments and cold sore treatments are skin conditions that most sufferers... Euromonitor International's Medicated Skin Care in Denmark report offers a comprehensive guide to the size ...
March 2012
32 pages
Compulsory License: India Pharma’s solution to “Patent and Affordability”
US$ 140.00
Recently, Natco was granted the first Compulsory License in India for the anti-cancer drug ‘Nexavar’. In an early test of India’s requirement that patent monopolies will ... now give rise to opportunities for other large cap global pharma companies too, as they can also seek a CL for other best ...
March 2012
8 pages
Assessment of the Japan Generics Industry
US$ 800.00
Executive
While Japan is the second largest pharma market globally, it has a very low penetration rate of generic drugs. The country’s government has set an ambitious goal to enhance the generic...
March 2012
25 pages
Medicated Skin Care in New Zealand
US$ 990.00
... hundreds of regulations that are considered to hinder business practice in New Zealand. With regard to medicated skin care, this review was intended to reduce compliance costs for ... Regulations Act 1984 as ‘a product that is primarily a food,... Euromonitor International's Medicated Skin Care in New Zealand report offers a comprehensive guide to the size and shape of the ...
March 2012
36 pages
Calming and Sleeping in Bolivia
US$ 990.00
During the review period, consumer lifestyles in Bolivia became busier and more stressful due to economic development, longer ... complaints, these trends continued to drive demand for calming and sleeping products in... Euromonitor International's Calming and Sleeping in Bolivia report offers a comprehensive guide to the size ...
March 2012
21 pages
Medicated Skin Care in Bolivia
US$ 990.00
... from. This trend continued to drive demand for medicated skin care products in 2011. Euromonitor International's Medicated Skin Care in Bolivia report offers a comprehensive guide to the size and ... and Allergy Remedies, Paediatric Digestive Remedies, Paediatric Medicated Skin Care, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical ...
March 2012
30 pages
Medicated Skin Care in Bulgaria
US$ 990.00
... . Nizoral from Johnson & Johnson Bulgaria EOOD and Allergosan from Sopharma AD are the most popular brands in medicated skin care, and they retain their traditional popularity largely without significant marketing activities by their manufacturers. Euromonitor International's Medicated Skin Care in Bulgaria report offers ...
March 2012
24 pages
